Company Profile
Updated: 27-OCT-09Indena S.p.A.
Non-Quoted Public Company
Viale Ortles 12, Milano, I-20139, Italy
()39 02 574961, 39 02 57404620 fax, http://www.indena.it
Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: Research, manufacture and sale of extracts and derivatives of plants for the pharmaceutical, cosmetics and health food industries
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Publication No. WO/2009/153025 Published on Dec. 23, Assigned to Indena for Bisindole Alkaloid Derivative Preparation Process (Italian Inventors)
US Fed News Service, Including US State News; 12/24/2009; 368 words; ...Italy, have developed a process for the preparation of bisindole alkaloid derivatives. The patent has been assigned to Indena S.p.A., Milano, Italy. According to an abstract posted by the World Intellectual Property Organization: "A process...
Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities.
PR Newswire; 12/8/2009; 1163 words; ...Acquires Arizona Production Facility 15 Indena Inks Worldwide License Agreement...Bags Paclitaxel Supply Contract 16 Indena Establishes New Plant to Produce...USA) 19 Hospira, Inc. (USA) 20 Indena S.p.A. (Italy) 20 OncoGenex Pharmaceuticals...
Publication No. WO/2009/143930 Published on Dec. 3, Assigned to Indena for Colchicine, Thiocolchicine Glycosidation Process (Italian Inventors)
US Fed News Service, Including US State News; 12/7/2009; 374 words; ...have developed a process for the glycosidation of colchicine and thiocolchicine. The patent has been assigned to Indena S.p.A., Milan, Italy. According to an abstract posted by the World Intellectual Property Organization: "A process...
Publication No. WO/2009/129926 Published on Oct. 29, Assigned to Indena for Composition, Infection Prevention (Italian Inventors)
US Fed News Service, Including US State News; 10/31/2009; 385 words; ...the compositions for the treatment and prevention of infections of the oral cavity. The patent has been assigned to Indena S.p.a., Milano, Italy. According to an abstract posted by the World Intellectual Property Organization: "The present...
Publication No. WO/2009/129927 Published on Oct. 29, Assigned to Indena for Composition, Chronic Inflammation (Italian Inventors)
US Fed News Service, Including US State News; 10/31/2009; 394 words; ...the compositions for the treatment of vaginal infections with chronic inflammation. The patent has been assigned to Indena S.p.a., Milano, Italy. According to an abstract posted by the World Intellectual Property Organization: "The present...
Recent News Articles
- Indena.(Company overview)
Nutraceuticals World - March 01, 2009 - Indena partners Gum Base on nutra gum.
Nutraceuticals International - November 01, 2008 - Indena, Milan, Italy, has received validation for its Opextan and Zanthalene products for use in cosmetic formulations, according to Ecocert ecological and organic standards.(Recent Certifications & Approvals)
Nutraceuticals World - November 01, 2008 - Indena obtains Ecocert approval.(TECHNOLOGY & PACKAGING)(natural and organic beauty products Opextan and Zanthalene)(Brief article)
Cosmetics International - October 03, 2008
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
Related Company Profiles
- Hebei Yiheng Group Company Ltd.
- Hebei Yiling Pharmaceutical Group
- Shandong Zhenxing Group General Corp.